Summary: In a four-arm trial in men with type 2 diabetes, combining 12 weeks of exercise with broccoli-sprout supplementation gave the largest improvements in apolipoproteins and glucose markers, but the effect was driven mainly by exercise, with the supplement adding complementary, less consistent benefit.
PICO Summary
| Element | Detail |
|---|---|
| Population | 44 men with type 2 diabetes; 12-week randomised trial, Iran. |
| Intervention | Concurrent resistance and aerobic training plus 10 g/day broccoli-sprout supplement (training + supplement group). |
| Comparison | Control, supplement-only, and training-only groups. |
| Outcome | The combined group showed the largest changes: ApoB-100 -48.30, ApoJ -44.05, ApoA-I +44.92 mg/dL, with large effect sizes for glucose, insulin, and HOMA-IR. Main-effect analysis showed exercise produced the substantial improvements; supplementation had moderate, less consistent effects. The authors conclude the benefit was largely exercise-driven. |
Exercise + broccoli sprouts and atherogenic lipoproteins
RCT · type 2 diabetes · 12 weeks
Combined exercise plus broccoli-sprout supplementation produced the largest apolipoprotein improvements over 12 weeks, but main-effect analysis shows the benefit was driven mainly by exercise, with the supplement adding a complementary, less consistent effect.
Expert Commentary
This is a nicely designed four-arm trial whose factorial structure lets us see not just that a combination works but which component does the heavy lifting, and the honest answer matters here. The apolipoprotein outcomes are clinically sensible targets, ApoB indexes the number of atherogenic particles and ApoA-I the protective HDL fraction, so a simultaneous fall in ApoB and rise in ApoA-I is a genuinely favourable shift in a high-risk population. But the main-effect analysis is clear that exercise drove the improvements, with broccoli-sprout sulforaphane contributing a complementary and less consistent effect rather than a co-equal one. That is the message to keep front and centre: this is an exercise study that a functional food modestly augments, not evidence that sprouts rival training. The limitations reinforce caution, only men, a small sample split across four arms, twelve weeks, and biomarker rather than event endpoints. Can I use this with my patients? Yes, with the emphasis right. It supports recommending consistent combined exercise as the foundation for cardiometabolic risk in diabetic patients, while noting that sulforaphane-rich foods such as raw broccoli sprouts are a safe, plausible add-on, not a substitute for activity or lipid-lowering therapy.
References
Delfan M, Gharedaghi M, Zeynali F, et al. Combined effects of exercise and broccoli supplementation on metabolic and lipoprotein biomarkers in adults with type 2 diabetes: a randomized controlled trial. Nutrients. 2025;17(17):2735. doi:10.3390/nu17172735